Healthcare Triangle, Inc.
HCTI · NASDAQ Capital Market · USD
4,22USD
+0,52 (+14,05 %)Stand 9. Nov., 21:00
Nachbörslich4,44+0,22 (+5,21 %)19:53 ET
Kennzahlen
- Eröffnung
- 3,98
- Vortag
- 3,70
- Tagesspanne
- 3,63 – 4,38
- 52 Wochen
- 3,51 – 3.390,00
- Volumen
- 61.535
- Ø Volumen
- 100.279
- Börsenwert
- 3,16 Mio. $
- KGV
- -0,0
- Gewinn je Aktie (TTM)
- -1.311,60
- Dividendenrendite
- 0,0 %
- Beta
- 1,2
- Nächste Zahlen
- 12. Nov. 2026
Finanzen
| USD | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Umsatz | 13,89 Mio. | 11,7 Mio. | 33,2 Mio. | 45,89 Mio. | 35,27 Mio. |
| Herstellungskosten | 12 Mio. | 8,81 Mio. | 26,43 Mio. | 34,59 Mio. | 24,75 Mio. |
| Bruttogewinn | 1,89 Mio. | 2,89 Mio. | 6,78 Mio. | 11,3 Mio. | 10,52 Mio. |
| Forschung und Entwicklung | 536.000 | 429.000 | 799.000 | 8,14 Mio. | 5,26 Mio. |
| Vertrieb und Verwaltung | 10,42 Mio. | 6,15 Mio. | 10,4 Mio. | 12,17 Mio. | 9,2 Mio. |
| Operatives Ergebnis | −9,79 Mio. | −4,75 Mio. | −7,7 Mio. | −16,32 Mio. | −5,36 Mio. |
| EBITDA | −8,2 Mio. | −3,86 Mio. | −6,12 Mio. | −10,7 Mio. | −3,94 Mio. |
| Nettogewinn | −9,48 Mio. | −5,97 Mio. | −8,69 Mio. | −14,36 Mio. | −5,95 Mio. |
| Gewinn je Aktie (verwässert) | -3.063,20 | -337.900,00 | -621.020,00 | -1.159.960,00 | -604.140,00 |
Umsatz nach Segment
Produkte · FY 2022
- Software Services23,88 Mio. $54,42 %+92,14 %
- Managed Services And Support15,18 Mio. $34,59 %−20,13 %
- Platform Services4,83 Mio. $10,99 %+25,76 %
Anteil · ggü. Vorjahr (FY 2021)
Bewertung
Letzte 12 Monate
- KGV
- -0,0
- Kurs-Umsatz-Verhältnis
- 0,1
- Kurs-Buchwert-Verhältnis
- 0,0
- PEG
- -0,0
- Bruttomarge
- 18,4 %
- Operative Marge
- −57,4 %
- Nettomarge
- −66,3 %
- Verschuldungsgrad
- 0,3
- EV/EBITDA
- -1,0
- Eigenkapitalrendite
- −56,5 %
- Kapitalrendite (ROIC)
- −21,9 %
- Free-Cashflow-Rendite
- −748,9 %
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Bruttomarge | 13,6 % | 24,7 % | 20,4 % | 24,6 % | 29,8 % |
| Operative Marge | −70,5 % | −40,6 % | −23,2 % | −35,6 % | −15,2 % |
| Nettomarge | −68,2 % | −51,0 % | −26,2 % | −31,3 % | −16,9 % |
| KGV | -0,2 | -0,9 | -1,3 | -0,5 | -8,9 |
| Kurs-Umsatz-Verhältnis | 0,2 | 0,4 | 0,3 | 0,1 | 1,5 |
| Kurs-Buchwert-Verhältnis | 0,2 | -1,0 | -8,2 | 1,1 | 3,3 |
| Verschuldungsgrad | 1,1 | -0,5 | -2,8 | 0,4 | 0,2 |
| Liquidität 3. Grades | 1,0 | 0,2 | 0,7 | 1,2 | 1,9 |
| Dividendenrendite | 0,0 % | 0,0 % | 0,0 % | 0,0 % | 0,0 % |
| Unternehmenswert | 5,46 Mio. | 7,89 Mio. | 14,07 Mio. | 7,73 Mio. | 54,54 Mio. |
| EV/EBITDA | -0,7 | -2,0 | -2,3 | -0,7 | -13,9 |
| Eigenkapitalrendite | −94,9 % | 116,7 % | 624,4 % | −237,7 % | −36,9 % |
| Kapitalrendite (ROIC) | −47,3 % | 192,8 % | −308,5 % | −174,6 % | −24,6 % |
| Free-Cashflow-Rendite | −703,6 % | −20,5 % | −18,9 % | −101,6 % | −19,4 % |
Wachstum
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Umsatz | +18,8 % | −64,8 % | −27,6 % | +30,1 % | +12,5 % |
| Bruttogewinn | −34,6 % | −57,4 % | −40,0 % | +7,3 % | +35,2 % |
| Operatives Ergebnis | −106,0 % | +38,3 % | +52,9 % | −204,6 % | −555,3 % |
| Nettogewinn | −58,8 % | +31,3 % | +39,5 % | −141,4 % | −352,8 % |
| Gewinn je Aktie | +99,1 % | +45,6 % | +46,5 % | −92,0 % | −402,3 % |
| Freier Cashflow | −1.428,5 % | +50,0 % | +66,7 % | +36,7 % | −1.294,0 % |
| Dividende je Aktie | 0,0 % | 0,0 % | 0,0 % | 0,0 % | 0,0 % |
Analysten
Einstufungen · Buy
- 0Stark kaufen
- 1Kaufen
- 0Halten
- 0Verkaufen
- 0Stark verkaufen
Kursziel
Gerade nicht verfügbar.
Schätzungen
| FY 2026 | FY 2027 | |
|---|---|---|
| Umsatz (Ø) | 38,84 Mio. | 40,54 Mio. |
| Umsatz (Tief – Hoch) | 38,84 Mio. – 38,84 Mio. | 40,54 Mio. – 40,54 Mio. |
| Gewinn je Aktie (Ø) | -204,60 | -63,60 |
| Gewinn je Aktie (Tief – Hoch) | -204,60 – -204,60 | -63,60 – -63,60 |
| Analysten | 1 | 1 |
Letzte Änderungen
- EF Hutton28. Sept. 2022Buy
- EF Hutton14. März 2022Buy
Quartalszahlen
Nächste Zahlen: 12. Nov. 2026| Aug. 2026 | Mai 2026 | März 2026 | Nov. 2025 | Aug. 2025 | Mai 2025 | März 2025 | Nov. 2024 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | -68,60 | -136,80 | -4,00 | -13,17 | -89.640,00 | -89.640,00 | -119.520,00 | -119.520,00 |
| Gewinn je Aktie · Tatsächlich | -31,20 | -6,84 | -1,40 | -25,15 | -34,73 | -2.544,91 | -3.443,11 | -3.293,41 |
| Abweichung | +54,52 % | +95,00 % | +65,00 % | −90,96 % | +99,96 % | +97,16 % | +97,12 % | +97,24 % |
| Umsatz · Tatsächlich | 9,19 Mio. | 9,86 Mio. | 3,14 Mio. | 3,49 Mio. | 3,56 Mio. | 3,7 Mio. | 2,19 Mio. | 2,41 Mio. |
Dividenden und Splits
Keine Dividenden gezahlt.
Aktiensplits
- 26. Okt. 20261:20
- 10. Feb. 20261:60
- 1. Aug. 20251:249
- 26. Mai 20231:10
Eigentümer
Institutionen
Q2 2026 · 13F
- Anteil institutioneller Investoren
- 1,54 %
- Investoren mit 13F-Meldung
- 8
Größte Investoren
- BANK OF MONTREAL /CAN/0,71 %20.000
- GEODE CAPITAL MANAGEMENT, LLC0,43 %11.975
- UBS GROUP AG0,32 %8859
- TOWER RESEARCH CAPITAL LLC (TRC)0,05 %1314
- VANGUARD CAPITAL MANAGEMENT LLC0,03 %859
- BARCLAYS PLC0,01 %310
- JPMORGAN CHASE & CO0,00 %20
- DANSKE BANK A/S0,00 %1
Insider-Geschäfte
- Kannappan Lakshmanan31. März 2025 · officer: Business HeadKauf304.180 Aktien
- Kizhakevilayil Shibu31. März 2025 · director, officer: Head of M&AKauf34.129 Aktien
- Ramachandran Thyagarajan31. März 2025 · officer: Chief Financial OfficerKauf14.627 Aktien
- SECUREKLOUD TECHNOLOGIES, INC.31. März 2025 · 10 percent ownerVerkauf2,55 Mio. Aktien
- Bhuiyan Mohammad Jainal12. März 2024 · directorKauf5000 Aktien · 1,78
- McClurg Ronald W.12. März 2024 · directorKauf5000 Aktien · 1,78
- Rosa David A12. März 2024 · directorKauf10.000 Aktien · 1,78
- Ramachandran Thyagarajan15. Nov. 2022 · officer: Chief Financial OfficerKauf100.000 Aktien · 0,19
Vergleichbare Unternehmen
Über das Unternehmen
Healthcare Triangle, Inc. (HCTI) is a technology firm dedicated to the healthcare sector, specializing in crafting innovative solutions across cloud services, data science, and professional and managed IT support. The company provides a comprehensive array of software, platforms, and services designed to empower healthcare and pharmaceutical organizations. These offerings help facilitate personalized treatment plans, accelerate precision medicine initiatives, drive innovation in drug discovery and development, foster collaborative research efforts, enable evidence-based decision-making, and streamline digital transformation. Among its proprietary software offerings are CloudEz, an enterprise platform streamlining multi-cloud migration and oversight, allowing clients to unify management of their private, hybrid, and public cloud environments. Another key platform is DataEz, a cloud-native solution providing robust data analytics and scientific data processing capabilities tailored for the life sciences, pharmaceutical, and healthcare provider sectors. Additionally, the company offers Readabl.AI, a Software-as-a-Service (SaaS) solution leveraging public cloud-based artificial intelligence and machine learning to intelligently identify and extract vital healthcare data from diverse documents such as faxes and narrative reports. Beyond its platforms, Healthcare Triangle delivers a range of cloud-centric IT services and specialized healthcare IT support. This includes the implementation, optimization, and integration of electronic health records (EHR) systems with community partners, comprehensive application managed services, and reliable public cloud-based backup and disaster recovery solutions. Its diverse client base spans healthcare providers, insurance carriers, pharmaceutical and life sciences firms, biotechnology companies, and medical device manufacturers. Established in 2019, Healthcare Triangle, Inc. operates out of Pleasanton, California, as a subsidiary of SecureKloud Technologies, Inc.
Führung
- David AyanoglouChief Financial Officer
- Sujatha RameshPrincipal Executive Officer (SEC), COO & Executive Director
- Jason MudrickHead of Practice of Epic
- Karen HughesHead of Practice of Meditech
- Shelly PierceHead of Human Resources & Talent Acquisition
- Ronald BetetaHead of Customer Success
- CEO
- Lakshmanan Kannappan
- Mitarbeitende
- 40
- Hauptsitz
- Pleasanton, CA, US
- Sektor
- Healthcare
- Branche
- Medical - Healthcare Information Services
- Börsengang
- 13. Okt. 2021
- Website
- healthcaretriangle.com
Nachrichten
- PRNewsWire · 2. Nov., 9:15Healthcare Triangle Expands into Indonesia; Identifying USD 45 Million Opportunity
- PRNewsWire · 26. Okt., 7:00Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia
- PRNewsWire · 22. Okt., 7:00Three Months In, HCTI's Purpose Health Lands Multiple Wins as AI-Led Momentum Builds
- GuruFocus · 21. Okt., 23:00Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan
- PRNewsWire · 21. Okt., 22:00Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan
- PRNewsWire · 20. Okt., 9:20HCTI Expands AI Business with 6 New Contracts, Targeting approx. $4.65M in Annual Run Rate Revenue
- GuruFocus · 30. Sept., 15:00Healthcare Triangle, Inc Signs MOU to Bring AI-Enabled Humanoid Nursing Robots to Hospitals in North America
- PRNewsWire · 30. Sept., 14:00Healthcare Triangle, Inc Signs MOU to Bring AI-Enabled Humanoid Nursing Robots to Hospitals in North America
- PRNewsWire · 23. Sept., 9:17Healthcare Triangle Signs Letter of Intent to Pursue the Proposed Acquisition of Roboticom's Cutting-Edge Industrial Precision Robotics Automation Business
- GuruFocus · 17. Sept., 16:00Healthcare Triangle (Nasdaq: HCTI) Joins Kanzun-ARCB Growth Fund to Build Malaysia-to-US Corridor for AI and Healthcare Companies
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.